University of Oxford
University Offices
Wellington Square
Oxford
England
OX1 2JD
United Kingdom
Website: http://www.ox.ac.uk/index.html
242 articles about University of Oxford
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 16, 2021.
-
Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimer’s disease
2/11/2021
Neuroinflammation collaboration targeting inflammasome steps-up-the-pace in race for Alzheimer’s disease medicines that alleviate the burden of devastating disease
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 9, 2021.
-
South Africa has delayed the distribution of the AstraZeneca-University of Oxford COVID-19 vaccine after data suggested it “provides minimal protection” against mild disease from the South African variant.
-
It was a busy week for clinical trial updates. Here’s a look.
-
The University of Oxford in the U.K., with the National Immunisation Schedule Evaluation Consortium, is planning a trial to evaluate the use of first and second doses of different COVID-19 vaccines.
-
Although designed for two doses, primary analysis of AstraZeneca and the University of Oxford’s Phase III data for its COVID-19 vaccine found it to have 76% efficacy after the first dose.
-
Clinical Catch-Up: December 14-18
12/21/2020
Many companies appear to be getting their clinical trial news updated ahead of the holidays. Here’s a look. -
Vir and GSK Dose First Patient in COVID-19 Monoclonal Antibody Study and Other Pandemic Updates
12/18/2020
Vir Biotechnology and GlaxoSmithKline dosed the first patient in a new sub-trial of a Phase III study assessing the monoclonal antibody VIR-7831 as a potential treatment of hospitalized adults diagnosed with COVID-19. -
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 15, 2020.
-
Research Roundup: Huntington’s Mutation Linked to Frontotemporal Dementia and ALS and More
12/11/2020
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones. -
AstraZeneca, which is jointly developing a COVID-19 vaccine with the University of Oxford, plans to begin clinical trials testing its vaccine in combination with Russia’s Sputnik V vaccine by the end of the year.
-
AstraZeneca and the University of Oxford published an interim analysis of their four Phase III clinical trials of AZD1222, their COVID-19 vaccine.
-
RA Capital Management Leads $45M Series A Financing for PepGen’s Next-Generation Oligonucleotide Platform Targeting Duchenne Muscular Dystrophy and Other Rare Neuromuscular and Cardiac Diseases
12/9/2020
PepGen’s proprietary cell-penetrating peptide technology promises enhanced safety, efficacy, and improved delivery to cardiac muscle; Oxford Sciences Innovation, The University of Oxford, and CureDuchenne Ventures also participated in the Series A round
-
Biopharma companies who have COVID-19 vaccines in development, have astonished skeptics by the speed with which they have developed vaccines.. But now comes an even more daunting challenge—scaling up manufacturing and distribution.
-
Clinical Catch-Up: November 23-27
11/30/2020
As the U.S. went into its Thanksgiving holiday week, clinical trial news was quieter than usual, although there was a lot of important news on the COVID-19 vaccine front. Here’s a look. -
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 24, 2020.
-
AstraZeneca and the University of Oxford announced results from an interim analysis of their COVID-19 vaccine, AZD1222. The analysis was from the trials in the UK and Brazil and demonstrated efficacy of up to 90%.
-
Evox Therapeutics announces launch of strategic collaboration with the University of Oxford
11/17/2020
Collaboration with world-renowned research centre to accelerate development of exosome therapies for rare diseases